Glass-ceramics with the composition BO-BiO-SrF were synthesized by the conventional melt-quenching technique and subsequent crystallization of the parental glasses. The temperature at which the ceramization was carried out was selected based on differential scanning calorimetry (DSC) analysis. The structure of the studied materials and the formation of SrF nanocrystals were confirmed by the Fourier-transform infrared spectroscopy (FTIR), X-ray diffraction (XRD), and X-ray photoelectron spectroscopy (XPS) techniques. It was found that the amount of strontium fluoride introduced into the parental borate-bismuth glass has a significant impact on the growth of SrF nanocrystals. In particular, the influence of the crystalline SrF phase on luminescence intensity and kinetics was studied using EuO-doped samples. An increase in luminescence intensity was observed in the samples in which SrF nanocrystals were formed. This is most likely related to the fact that some of the Eu ions were (after annealing of the glass) located in the crystalline structure of strontium fluoride. This was confirmed both by the luminescence lifetime obtained based on the luminescence decay curves and the calculated Judd-Ofelt parameters, Ω and Ω. The results achieved confirm that the glasses and glass-ceramics described in this work could be considered as a new phosphor for light-emitting diodes (LEDs).
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8401422 | PMC |
http://dx.doi.org/10.3390/ma14164490 | DOI Listing |
Sci Rep
December 2024
Department of Pharmacy, Faculty of Pharmacy, Mahidol University, 447 Sri-Ayuthaya Road, Rajathevi, Bangkok, 10400, Thailand.
This study aims to develop a self-nanoemulsifying drug delivery system (SNEDDS) to solve the limited oral bioavailability problem of apigenin, a bioactive flavonoid. Apigenin-loaded SNEDDS consisting of Gelucire 44/14, Tween 80, and PEG 400 in the mass ratios of 25:37.5:37.
View Article and Find Full Text PDFNanoscale Adv
November 2024
Centre for Nanobiotechnology, VIT University Vellore 632 014 India +91-416-2243092 +91-416-220-2879.
Liver cancer, with its robust metastatic propensity, imposes a substantial global health burden of around 800 000 new cases annually. Mutations in the Wnt/β-catenin pathway genes are common in liver cancer, driving over 80% of cases. Targeting this pathway could potentially lead to better treatments.
View Article and Find Full Text PDFJ Nanobiotechnology
October 2024
Henan Institute of Medical and Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, 450052, China.
Ferroptosis has emerged as a promising strategy for cancer treatment. Nevertheless, the efficiency of ferroptosis-mediated therapy remains a challenge due to high glutathione (GSH) levels and insufficient endogenous hydrogen peroxide in the tumor microenvironment. Herein, we presented a nitric-oxide (NO) boost-GSH depletion strategy for enhanced ferroptosis therapy through a multifunctional nanoplatform with near-infrared (NIR) triggered NO release.
View Article and Find Full Text PDFDrug Deliv Transl Res
October 2024
Department of Molecular Imaging, The First Affiliated Hospital of Qiqihar Medical University, Qiqihar, 101006, China.
Undifferentiated thyroid cancer (ATC) is highly malignant and does not respond well to sorafenib (SRF) treatment owing to the lack of specificity of SRF targeting. Drug delivery nanosystems can improve the efficiencies of drug in treating various cancer types. However, many conventional drug delivery nanosystems lack targeting and exhibit unresponsive drug release.
View Article and Find Full Text PDFBiomater Adv
January 2025
State Key Laboratory of Advanced Technology for Materials Synthesis and Processing, Wuhan University of Technology, Wuhan 430070, China; National Energy Key Laboratory for New Hydrogen-Ammonia Energy Technologies, Foshan Xianhu Laboratory, Foshan 528200, China. Electronic address:
Chemodynamic therapy (CDT) guided by Fenton chemistry and iron-containing materials can induce ferroptosis as a prospective cancer treatment method, but the inefficient Fe/Fe conversion restricts the monotherapeutic performances. Here, an iron-based nanoplatform (FeO-SRF@FeTA) including a magnetic core and a reductive film is developed for combined CDT and photothermal therapy (PTT) through ferroptosis augmentation. The inner iron oxide core serves as a photothermal transducer, a magnet-responsive module, and an iron reservoir for CDT.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!